Cargando…
Revisit (18)F-fluorodeoxyglucose oncology positron emission tomography: “systems molecular imaging” of glucose metabolism
(18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography has become an important tool for detection, staging and management of many types of cancer. Oncology application of (18)F-FDG bases on the knowledge that increase in glucose demand and utilization is a fundamental features of cancer....
Autores principales: | Shen, Baozhong, Huang, Tao, Sun, Yingying, Jin, Zhongnan, Li, Xiao-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522167/ https://www.ncbi.nlm.nih.gov/pubmed/28402949 http://dx.doi.org/10.18632/oncotarget.16647 |
Ejemplares similares
-
Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using (18)F-fluorodeoxyglucose positron emission tomography
por: Aoyama, Rie, et al.
Publicado: (2017) -
Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009) -
Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020) -
Neurolymphomatosis detected by (18)F‐fluorodeoxyglucose‐positron emission tomography
por: Hori, Yoshikazu, et al.
Publicado: (2020) -
Severe myocardial ischemia detected in routine oncological positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose
por: Freitag, Martin T, et al.
Publicado: (2023)